The ROE as of January 2025 (TTM) for Zelira Therapeutics Limited (ZLD.AX) is 1.07%

According to Zelira Therapeutics Limited’s latest financial reports and current stock price. The company's current ROE is 1.07%. This represents a change of 185.46% compared to the average of 373.73% of the last 4 quarters.

Zelira Therapeutics Limited (ZLD.AX) Historical ROE (quarterly & annually)

How has ZLD.AX ROE performed in the past?

The mean historical ROE of Zelira Therapeutics Limited over the last ten years is 82.61%. The current 1.07% ROE has changed 1.19% with respect to the historical average. Over the past ten years (40 quarters), ZLD.AX's ROE was at its highest in in the December 2023 quarter at 1.46%. The ROE was at its lowest in in the December 2016 quarter at -151.52%.

Zelira Therapeutics Limited (ZLD.AX) ROE by Quarter and Year

Discovering the peaks and valleys of Zelira Therapeutics Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Zelira Therapeutics Limited (ZLD.AX) Average ROE

How has ZLD.AX ROE performed in the past?

The current ROE of Zelira Therapeutics Limited (ZLD.AX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Zelira Therapeutics Limited (ZLD.AX) ROE vs. Peers

How is ZLD.AX’s ROE compared to its peers?

Zelira Therapeutics Limited’s ROE is greater than Creso Pharma Limited (-130.99%), less than MGC Pharmaceuticals Limited (562.83%), greater than Botanix Pharmaceuticals Limited (-18.00%), greater than Cann Group Limited (-159.56%), greater than Althea Group Holdings Limited (-414.04%),

Build a custom stock screener for Zelira Therapeutics Limited (ZLD.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Zelira Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Zelira Therapeutics Limited (ZLD.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Zelira Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.